Lise Jamieson

1.0k total citations
44 papers, 490 citations indexed

About

Lise Jamieson is a scholar working on Infectious Diseases, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Lise Jamieson has authored 44 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 14 papers in Epidemiology and 14 papers in Economics and Econometrics. Recurrent topics in Lise Jamieson's work include HIV/AIDS Research and Interventions (27 papers), HIV/AIDS Impact and Responses (11 papers) and HIV, Drug Use, Sexual Risk (9 papers). Lise Jamieson is often cited by papers focused on HIV/AIDS Research and Interventions (27 papers), HIV/AIDS Impact and Responses (11 papers) and HIV, Drug Use, Sexual Risk (9 papers). Lise Jamieson collaborates with scholars based in South Africa, United States and United Kingdom. Lise Jamieson's co-authors include Gesine Meyer‐Rath, Leigh F. Johnson, Sydney Rosen, Brooke E Nichols, Lawrence Long, Bruce A. Larson, Mhairi Maskew, Ian Sanne, Matthew P. Fox and Ijeoma Edoka and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lise Jamieson

38 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lise Jamieson South Africa 13 352 183 110 79 68 44 490
Joyce Wamicwe Kenya 11 276 0.8× 190 1.0× 128 1.2× 28 0.4× 43 0.6× 24 389
Lauren Shaw United States 13 191 0.5× 118 0.6× 120 1.1× 48 0.6× 74 1.1× 20 573
Adesola Zaidat Musa Nigeria 9 182 0.5× 74 0.4× 84 0.8× 47 0.6× 54 0.8× 41 302
Caitlin M. Dugdale United States 12 293 0.8× 159 0.9× 95 0.9× 33 0.4× 48 0.7× 41 460
Ifeoma Idigbe Nigeria 10 192 0.5× 101 0.6× 122 1.1× 48 0.6× 34 0.5× 53 347
Nathaniel Chishinga Zambia 10 397 1.1× 244 1.3× 174 1.6× 64 0.8× 36 0.5× 21 669
Issifou Yaya France 13 252 0.7× 235 1.3× 134 1.2× 25 0.3× 41 0.6× 48 514
Cleophas Chimbetete Switzerland 14 424 1.2× 139 0.8× 63 0.6× 39 0.5× 92 1.4× 51 547
Gifty Marley China 15 359 1.0× 255 1.4× 103 0.9× 41 0.5× 24 0.4× 52 595
Charles Chasela South Africa 14 308 0.9× 172 0.9× 114 1.0× 48 0.6× 76 1.1× 37 451

Countries citing papers authored by Lise Jamieson

Since Specialization
Citations

This map shows the geographic impact of Lise Jamieson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lise Jamieson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lise Jamieson more than expected).

Fields of papers citing papers by Lise Jamieson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lise Jamieson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lise Jamieson. The network helps show where Lise Jamieson may publish in the future.

Co-authorship network of co-authors of Lise Jamieson

This figure shows the co-authorship network connecting the top 25 collaborators of Lise Jamieson. A scholar is included among the top collaborators of Lise Jamieson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lise Jamieson. Lise Jamieson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jo, Youngji, et al.. (2025). Integrated multi‐month dispensing for HIV and hypertension in South Africa: A model of epidemiological impact and cost‐effectiveness. Journal of the International AIDS Society. 28(2). e26413–e26413.
2.
Meyer‐Rath, Gesine, Lise Jamieson, Edinah Mudimu, Jeffrey W. Eaton, & Leigh F. Johnson. (2025). The cost of the plunge: the impact and cost of a cessation of PEPFAR-supported services in South Africa. AIDS. 39(10). 1476–1480. 1 indexed citations
3.
Jamieson, Lise, Leigh F. Johnson, Jeffrey W. Eaton, et al.. (2025). Taking injectable PrEP to scale: Optimising the value of lenacapavir for South Africa’s HIV response. medRxiv.
4.
Moore, Mia, Lise Jamieson, Gesine Meyer‐Rath, et al.. (2025). Estimated impact of long‐acting injectable PrEP in South Africa: a model comparison analysis. Journal of the International AIDS Society. 28(S2). e26453–e26453.
5.
Meyer‐Rath, Gesine, Lise Jamieson, Edinah Mudimu, et al.. (2025). Who pays and what pays off in sexual and reproductive health? A review of the cost and cost-effectiveness of interventions and implications for future funding and markets. The Lancet. 406(10515). 2152–2167. 1 indexed citations
6.
Jamieson, Lise, Cari van Schalkwyk, Brooke E Nichols, et al.. (2023). Differential in-hospital mortality and intensive care treatment over time: Informing hospital pathways for modelling COVID-19 in South Africa. SHILAP Revista de lepidopterología. 3(5). e0001073–e0001073. 3 indexed citations
7.
Silal, Sheetal, Juliet R.C. Pulliam, Gesine Meyer‐Rath, et al.. (2023). The National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa. SHILAP Revista de lepidopterología. 3(4). e0001070–e0001070. 5 indexed citations
8.
Meyer‐Rath, Gesine, Lise Jamieson, & Yogan Pillay. (2023). What will it take for an injectable ARV to change the face of the HIV epidemic in high‐prevalence countries? Considerations regarding drug costs and operations. Journal of the International AIDS Society. 26(S2). e26106–e26106. 11 indexed citations
9.
Meyer‐Rath, Gesine, Rachel Hounsell, Juliet R.C. Pulliam, et al.. (2023). The role of modelling and analytics in South African COVID-19 planning and budgeting. SHILAP Revista de lepidopterología. 3(7). e0001063–e0001063. 2 indexed citations
10.
11.
Edoka, Ijeoma, et al.. (2021). Inpatient Care Costs of COVID-19 in South Africa’s Public Healthcare System. International Journal of Health Policy and Management. 11(8). 1354–1361. 23 indexed citations
12.
Jo, Youngji, Lise Jamieson, Ijeoma Edoka, et al.. (2021). Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa. Open Forum Infectious Diseases. 8(3). ofab040–ofab040. 33 indexed citations
13.
Nichols, Brooke E, Lise Jamieson, Sheetal Silal, et al.. (2020). The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity. Clinical Infectious Diseases. 72(9). 1642–1644. 12 indexed citations
14.
Nichols, Brooke E, Refiloe Cele, Lise Jamieson, et al.. (2020). Community-based delivery of HIV treatment in Zambia: costs and outcomes. AIDS. 35(2). 299–306. 23 indexed citations
15.
Meyer‐Rath, Gesine, et al.. (2019). The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case. PLoS ONE. 14(2). e0210497–e0210497. 48 indexed citations
16.
17.
Brennan, Alana T., Lise Jamieson, Nigel J. Crowther, et al.. (2018). Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa. PLoS ONE. 13(10). e0204020–e0204020. 58 indexed citations
18.
Meyer‐Rath, Gesine, et al.. (2017). Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case. PLoS ONE. 12(10). e0186496–e0186496. 35 indexed citations
19.
Johnson, Leigh F., et al.. (2017). Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?. BMC Public Health. 17(1). 143–143. 26 indexed citations
20.
Maskew, Mhairi, Matthew P. Fox, Denise Evans, et al.. (2016). Insights into Adherence among a Cohort of Adolescents Aged 12–20 Years in South Africa: Reported Barriers to Antiretroviral Treatment. AIDS Research and Treatment. 2016. 1–12. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joyce Wamicwe Breakdown of academic impact, for papers by Lauren Shaw Breakdown of academic impact, for papers by Adesola Zaidat Musa Breakdown of academic impact, for papers by Caitlin M. Dugdale Breakdown of academic impact, for papers by Ifeoma Idigbe Breakdown of academic impact, for papers by Nathaniel Chishinga Breakdown of academic impact, for papers by Issifou Yaya Breakdown of academic impact, for papers by Cleophas Chimbetete Breakdown of academic impact, for papers by Gifty Marley Breakdown of academic impact, for papers by Charles Chasela
Rankless by CCL
2026